Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countries
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/153981 |
Resumo: | Funding Information: We acknowledge the financial support from Dutch Heart Foundation, Lung Foundation Netherlands, Dutch Cancer Society, Dutch Diabetes Research Foundation, Netherlands Thrombosis Foundation, and Health Data Research UK. Publisher Copyright: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license |
id |
RCAP_c40ac7fdfa039cdb51fc0791957f1ddb |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/153981 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countriesa synthetic control studyPublic Health, Environmental and Occupational HealthSDG 3 - Good Health and Well-beingFunding Information: We acknowledge the financial support from Dutch Heart Foundation, Lung Foundation Netherlands, Dutch Cancer Society, Dutch Diabetes Research Foundation, Netherlands Thrombosis Foundation, and Health Data Research UK. Publisher Copyright: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 licenseBackground: There are few quantitative studies into the effect of comprehensive smoke-free legislation on neonatal and infant mortality in middle-income countries. We aimed to estimate the effects of implementing comprehensive smoke-free legislation on neonatal mortality and infant mortality across all middle-income countries. Methods: We applied the synthetic control method using 1990–2018 country-level panel data for 106 middle-income countries from the WHO, World Bank, and Penn World datasets. Outcome variables were neonatal (age 0–28 days) mortality and infant (age 0–12 months) mortality rates per 1000 livebirths per year. For each middle-income country with comprehensive smoke-free legislation, a synthetic control country was constructed from middle-income countries without comprehensive smoke-free legislation, but with similar prelegislation trends in the outcome and predictor variables. Overall legislation effect was the mean average of country-specific effects weighted by the number of livebirths. We compared the distribution of the legislation effects with that of the placebo effects to assess the likelihood that the observed effect was related to the implementation of smoke-free legislation and not merely influenced by other processes. Findings: 31 (29%) of 106 middle-income countries introduced comprehensive smoke-free legislation and had outcome data for at least 3 years after the intervention. We were able to construct a synthetic control country for 18 countries for neonatal mortality and for 15 countries for infant mortality. Comprehensive smoke-free legislation was followed by a mean yearly decrease of 1·63% in neonatal mortality and a mean yearly decrease of 1·33% in infant mortality. An estimated 12 392 neonatal deaths in 18 countries and 8932 infant deaths in 15 countries were avoided over 3 years following the implementation of comprehensive smoke-free legislation. We estimated that an additional 104 063 infant deaths (including 95 850 neonatal deaths) could have been avoided over 3 years if the 72 control middle-income countries had introduced this legislation in 2015. 220 (43%) of 514 placebo effects for neonatal mortality and 112 (39%) of 289 for infant mortality were larger than the estimated aggregated legislation effect, indicating a degree of uncertainty around our estimates. Sensitivity analyses showed results that were consistent with the main analysis and suggested a dose–response association related to comprehensiveness of the legislation. Interpretation: Implementing comprehensive smoke-free legislation in middle-income countries could substantially reduce preventable deaths in neonates and infants. Funding: Dutch Heart Foundation, Lung Foundation Netherlands, Dutch Cancer Society, Dutch Diabetes Research Foundation, Netherlands Thrombosis Foundation, Health Data Research UK.Centro de Investigação em Saúde Pública (CISP/PHRC)Comprehensive Health Research Centre (CHRC) - Pólo ENSPEscola Nacional de Saúde Pública (ENSP)RUNRadó, Márta K.van Lenthe, Frank J.Laverty, Anthony A.Filippidis, Filippos T.Millett, ChristopherSheikh, AzizBeen, Jasper V.2023-06-15T22:20:50Z2022-072022-07-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/153981eng2468-2667PURE: 63727343https://doi.org/10.1016/S2468-2667(22)00112-8info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:36:26Zoai:run.unl.pt:10362/153981Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:55:26.948798Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countries a synthetic control study |
title |
Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countries |
spellingShingle |
Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countries Radó, Márta K. Public Health, Environmental and Occupational Health SDG 3 - Good Health and Well-being |
title_short |
Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countries |
title_full |
Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countries |
title_fullStr |
Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countries |
title_full_unstemmed |
Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countries |
title_sort |
Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countries |
author |
Radó, Márta K. |
author_facet |
Radó, Márta K. van Lenthe, Frank J. Laverty, Anthony A. Filippidis, Filippos T. Millett, Christopher Sheikh, Aziz Been, Jasper V. |
author_role |
author |
author2 |
van Lenthe, Frank J. Laverty, Anthony A. Filippidis, Filippos T. Millett, Christopher Sheikh, Aziz Been, Jasper V. |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Centro de Investigação em Saúde Pública (CISP/PHRC) Comprehensive Health Research Centre (CHRC) - Pólo ENSP Escola Nacional de Saúde Pública (ENSP) RUN |
dc.contributor.author.fl_str_mv |
Radó, Márta K. van Lenthe, Frank J. Laverty, Anthony A. Filippidis, Filippos T. Millett, Christopher Sheikh, Aziz Been, Jasper V. |
dc.subject.por.fl_str_mv |
Public Health, Environmental and Occupational Health SDG 3 - Good Health and Well-being |
topic |
Public Health, Environmental and Occupational Health SDG 3 - Good Health and Well-being |
description |
Funding Information: We acknowledge the financial support from Dutch Heart Foundation, Lung Foundation Netherlands, Dutch Cancer Society, Dutch Diabetes Research Foundation, Netherlands Thrombosis Foundation, and Health Data Research UK. Publisher Copyright: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-07 2022-07-01T00:00:00Z 2023-06-15T22:20:50Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/153981 |
url |
http://hdl.handle.net/10362/153981 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2468-2667 PURE: 63727343 https://doi.org/10.1016/S2468-2667(22)00112-8 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138141524721664 |